《中国年轻乳腺癌诊疗专家共识(2022)》解读

Interpretation of the Expert consensus on the diagnosis and treatment of young breast cancer in China(2022 Edition)

乳腺癌是中国女性最常见的恶性肿瘤。年轻乳腺癌患者并不罕见,且具有独特的医疗需求。随着国内外临床研究的进展和国际共识指南的发布,年轻乳腺癌患者的诊疗也逐渐引起学界的广泛关注。2022年,为了规范和优化中国年轻乳腺癌的诊疗,中国年轻乳腺癌诊疗共识专家组发布了《中国年轻乳腺癌诊疗专家共识(2022)》。现笔者对该共识中的要点进行解读,以飨读者。

Breast cancer is the most common malignant tumor among Chinese women.Young breast cancer patients are not uncommon and have unique medical needs.With the progress of clinical research both domestically and internationally,and the release of international consensus and guidelines,the diagnosis and treatment of young breast cancer patients have gradually garnered widespread attention in the academic community.In 2022,to standardize and optimize the diagnosis and treatment of young breast cancer in China,the Expert Committee on Diagnosis and Treatment of Young Breast Cancer in China released the"Expert consensus on diagnosis and treatment of young breast cancer in China(2022 Edition)".Herein,the authors provide an interpretation of the key points within this consensus to better convey the information to readers.